Wang Aimin, Zhu Guangbin, Qian Ping, Zhu Tao
Department of Intensive Care Unit, Taicang Affiliated Hospital of Soochow University, Taicang, Jiangsu 215006, P.R. China.
Exp Ther Med. 2017 Sep;14(3):2392-2400. doi: 10.3892/etm.2017.4754. Epub 2017 Jul 10.
Traumatic brain injury (TBI) is a diverse group of intracranial injuries resulting from external mechanical insults to the brain. While basic and clinical research for TBI has been conducted for decades, it has not identified cost-effective medical interventions for treating TBI. Tetramethylpyrazine (TMP), which is derived from the Chinese herb, Hort (Chuan Xiong), has been clinically used for treating ischemic brain injury for years. However, whether TMP could provide effective benefits for improving the outcomes following TBI is unknown. In the present study, using controlled cortical impact (CCI) injury to create an animal model of TBI, the potential effects of TMP on improving blood-brain barrier (BBB) permeability in the early phase of the secondary injury, as well as the splenic anti-inflammatory activities, were evaluated. Cognitive functions were also assessed by Morris water maze trials following TBI. Results demonstrated that, at 24 h after CCI injury, BBB permeability was significantly reduced (P<0.05) by the application of TMP. In addition, within 24 h after CCI injury, the plasma levels of interleukin (IL)-1β and tumor necrosis factor (TNF)-α, and protein and mRNA expression levels of IL-1β and TNF-α in the spleen were significantly lowered by TMP (P<0.05). Furthermore, within 24 h after CCI injury, the activation of the splenic anti-inflammatory effects mediated by nicotinic acetylcholine receptor α7 (nAChRa7) stimulation were significantly enhanced by TMP (P<0.05). Additionally, impaired spatial memory acquisition and consolidation were significantly improved by TMP after CCI injury (P<0.05). Together, in light of these data, in the treatment of TBI, TMP could effectively reduce BBB permeability, which may be closely associated with the enhanced splenic anti-inflammatory effects activated by nAChRa7 stimulation, and potentially improve cognitive recovery concerning spatial learning and memory.
创伤性脑损伤(TBI)是由外部机械性脑损伤导致的一组多样的颅内损伤。尽管针对TBI的基础和临床研究已经开展了数十年,但尚未确定具有成本效益的治疗TBI的医学干预措施。川芎嗪(TMP)源自中药川芎,多年来一直临床上用于治疗缺血性脑损伤。然而,TMP是否能为改善TBI后的预后提供有效益处尚不清楚。在本研究中,使用控制性皮质撞击(CCI)损伤建立TBI动物模型,评估TMP对继发性损伤早期改善血脑屏障(BBB)通透性的潜在作用以及脾脏抗炎活性。TBI后还通过莫里斯水迷宫试验评估认知功能。结果表明,在CCI损伤后24小时,应用TMP可使BBB通透性显著降低(P<0.05)。此外,在CCI损伤后24小时内,TMP可显著降低脾脏中白细胞介素(IL)-1β和肿瘤坏死因子(TNF)-α的血浆水平以及IL-1β和TNF-α的蛋白质和mRNA表达水平(P<0.05)。此外,在CCI损伤后24小时内,TMP可显著增强由烟碱型乙酰胆碱受体α7(nAChRa7)刺激介导的脾脏抗炎作用的激活(P<0.05)。此外,CCI损伤后TMP可显著改善受损的空间记忆获取和巩固(P<0.05)。综上所述,根据这些数据,在TBI治疗中,TMP可有效降低BBB通透性,这可能与nAChRa7刺激激活的脾脏抗炎作用增强密切相关,并可能改善与空间学习和记忆相关的认知恢复。